Literature DB >> 34999985

Hypogammaglobulinaemia following rituximab therapy in childhood nephrotic syndrome.

Eugene Yu-Hin Chan1, Alison Lap-Tak Ma2, Kjell Tullus3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 34999985     DOI： 10.1007/s00467-021-05345-9

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  1 in total

1.  Incidence and risk factors of rituximab-associated hypogammaglobulinemia in patients with complicated nephrotic syndrome.

Authors:  Yuta Inoki; Koichi Kamei; Kentaro Nishi; Mai Sato; Masao Ogura; Akira Ishiguro
Journal:  Pediatr Nephrol       Date:  2021-10-04       Impact factor: 3.714
  1 in total
  1 in total

1.  Long-Term Efficacy and Safety of Repeated Rituximab to Maintain Remission in Idiopathic Childhood Nephrotic Syndrome: An International Study.

Authors:  Eugene Yu-Hin Chan; Ellen L M Yu; Andrea Angeletti; Zainab Arslan; Biswanath Basu; Olivia Boyer; Chang-Yien Chan; Manuela Colucci; Guillaume Dorval; Claire Dossier; Stefania Drovandi; Gian Marco Ghiggeri; Debbie S Gipson; Riku Hamada; Julien Hogan; Kenji Ishikura; Koichi Kamei; Markus J Kemper; Alison Lap-Tak Ma; Rulan S Parekh; Seetha Radhakrishnan; Priya Saini; Qian Shen; Rajiv Sinha; Chantida Subun; Sharon Teo; Marina Vivarelli; Hazel Webb; Hong Xu; Hui Kim Yap; Kjell Tullus
Journal:  J Am Soc Nephrol       Date:  2022-03-30       Impact factor: 14.978
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.